On WebMD, Chief Programs Officer Michelle Tregear writes:
By addressing barriers and coming up with ways to increase diversity in clinical trial participation, we can ensure that new cancer treatments are safe, effective, and meaningful to all groups… Everyone deserves the best possible care, and advancing diversity and participation in clinical trials is crucial to achieving that goal.
